Candel Therapeutics (NASDAQ:CADL) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Candel Therapeutics (CADL) operate in?

Candel Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Candel Therapeutics Stock (NASDAQ: CADL) stock price, news, charts, stock research, profile.

Open	$4.19
Close	$5.04
Volume / Avg.	2.31M / 281.15K
Day Range	$4.19 - $5.57
52 Wk Range	0.77 - 14.30
Market Cap	$166.27M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	53
Short Interest	7.92%
Days to Cover	7.2

Recent News

GeneDx Leads Russell 2000 This Year As It Shifts To More Comprehensive Genetic Testing (CORRECTED)

GeneDx Holdings Corp. (NASDAQ: WGS) has soared 1,101% this year, attributed to its mix shift towards exome/genome testing and record high margins.

Michael Juliano

Why BioRestorative Therapies Stock Is Moving Higher Thursday

BioRestorative Therapies announced before the market opened on Thursday that it engaged in substantive licensing discussions with a regenerative medicine company related to its ThermoStem Metabolic Disease Program intellectual property.

Dylan Berman

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.5

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$4.19
Close	$5.04
Volume / Avg.	2.31M / 281.15K
Day Range	$4.19 - $5.57
52 Wk Range	0.77 - 14.30
Market Cap	$166.27M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	53
Short Interest	7.92%
Days to Cover	7.2

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Candel Therapeutics (CADL) stock?

You can purchase shares of Candel Therapeutics (NASDAQ:CADL) through any online brokerage.

View our list of the best stock brokerages

Who are Candel Therapeutics (CADL) competitors?

Other companies in Candel Therapeutics’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Invizyne Technologies (NASDAQ:IZTC), Innate Pharma (NASDAQ:IPHA), Skye Bioscience (NASDAQ:SKYE) and Adverum Biotechnologies (NASDAQ:ADVM).

What is the forecast, or price target, for Candel Therapeutics (CADL) stock?

Candel Therapeutics has a consensus price target of $8.25.

What is the current price for Candel Therapeutics (CADL)?

The stock price for Candel Therapeutics (NASDAQ: CADL) is $5.12 last updated November 22, 2024 at 7:56 PM EST.

Does Candel Therapeutics (CADL) pay a dividend?

There are no upcoming dividends for Candel Therapeutics.

When is Candel Therapeutics (NASDAQ:CADL) reporting earnings?

Candel Therapeutics’s Q3 earnings are confirmed for Thursday, November 14, 2024.

Is Candel Therapeutics (CADL) going to split?

There is no upcoming split for Candel Therapeutics.

What sector and industry does Candel Therapeutics (CADL) operate in?

Candel Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Candel Therapeutics

Candel Therapeutics (CADL) Forecast